Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial

被引：42
|
作者：
Schneider, LS [1 ]
Ismail, MS [1 ]
Dagerman, K [1 ]
Davis, S [1 ]
Olin, J [1 ]
McManus, D [1 ]
Pfeiffer, E [1 ]
Ryan, JM [1 ]
Sultzer, DL [1 ]
Tariot, PN [1 ]
机构：
[1] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
来源：
SCHIZOPHRENIA BULLETIN | 2003年 / 29卷 / 01期
关键词：
Alzheimer's disease; atypical antipsychotic; psychosis; dementia; effectiveness;
D O I：
10.1093/oxfordjournals.schbul.a006991
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
This article describes the development of the protocol for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Alzheimer's disease trial, which was developed in collaboration with the National Institute of Mental Health to assess the effectiveness of atypical antipsychotics for psychosis and/or agitation occurring in outpatients with Alzheimer's disease. The article provides a detailed description of the methodology used in the trial as well as the clinical outcomes and effectiveness measures incorporated into it, discussing the most salient issues encountered in developing the design of the trial, as well as the unique features of the trial.
引用
收藏
页码：57 / 72
页数：16
相关论文
共 50 条
  • [21] Life Satisfaction Among Individuals With Schizophrenia in the Clinical Antipsychotic Trial of Intervention Effectiveness (CATIE) Study
    Fervaha, Gagan
    Agid, Ofer
    Takeuchi, Hiroyoshi
    Foussias, George
    Remington, Gary
    AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (09): : 1061 - 1062
  • [22] Relationship between antipsychotic blood levels and treatment failure during the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study
    Melkote, Rama
    Singh, Arun
    Vermeulen, An
    Remmerie, Bart
    Savitz, Adam
    SCHIZOPHRENIA RESEARCH, 2018, 201 : 324 - 328
  • [23] Correlation Between Violence and Antipsychotic Dosage in Schizophrenia: A Secondary Analysis of The Clinical Antipsychotic Trials for Intervention Effectiveness (CATIE) Dataset
    Tasmim, Samia
    Kolla, Nathan J.
    Dada, Oluwagbenga
    Bani-Fatemi, Ali
    De Luca, Vincenzo
    PHARMACOPSYCHIATRY, 2019, 52 (05) : 217 - 221
  • [24] Baseline neurocognitive assessment of 1364 patients with schizophrenia in the clinical antipsychotic trials for intervention effectiveness (CATIE) project
    Keefe, R
    Bilder, RM
    Palmer, B
    Harvey, PD
    Davis, S
    McEvoy, J
    Golberg, T
    Gold, J
    Green, MF
    Swartz, MS
    Stroup, S
    Rosenheck, R
    Perkins, D
    Meltzer, H
    Lieberman, JA
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 79S - 79S
  • [25] Baseline neurocognitive assessment of 1364 patients with schizophrenia in the clinical antipsychotic trials for intervention effectiveness (CATIE) project
    Keefe, R
    Bilder, RM
    Harvey, PD
    Davis, S
    Palmer, B
    McEvoy, JP
    Goldberg, TE
    Gold, JM
    Green, MR
    Swartz, M
    Stroup, S
    Rosenheck, R
    Perkins, DO
    Meltzer, HY
    Miller, D
    Canive, J
    Walker, TM
    Lieberman, JA
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 361 - 362
  • [26] Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: Phase 1 outcomes from the CATIE-AD effectiveness trial
    Sultzer, David L.
    Davis, Sonia M.
    Tariot, Pierre N.
    Dagerman, Karen S.
    Lebowitz, Barry D.
    Lyketsos, Constantine G.
    Rosenheck, Robert A.
    Hsiao, John K.
    Lieberman, Jeffrey A.
    Schneider, Lon S.
    AMERICAN JOURNAL OF PSYCHIATRY, 2008, 165 (07): : 844 - 854
  • [27] The relationship between suicide and violence in schizophrenia: Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) dataset
    Witt, Katrina
    Hawton, Keith
    Fazel, Seena
    SCHIZOPHRENIA RESEARCH, 2014, 154 (1-3) : 61 - 67
  • [28] Comparative effectiveness of antipsychotic drugs - A commentary on Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)
    Lieberman, Jeffrey A.
    ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (10) : 1069 - 1072
  • [29] Emerging issues in the NIMH CATIE Alzheimer's disease effectiveness trial.
    Olin, J
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 10 (02): : 45 - 46
  • [30] Prediction of quality of life in schizophrenia using machine learning models on data from Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial
    Mélissa Beaudoin
    Alexandre Hudon
    Charles-Edouard Giguère
    Stéphane Potvin
    Alexandre Dumais
    Schizophrenia, 8
12345